Eric Sherman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Eric Sherman

Showing results (41-50 of 92) with videos related to

Pageof 10

Sort By:

Oncoimmunology|July 12, 2023

Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironmentLinda Chen, Nancy Lee, Reith Sarkar, et al.

Biochimica Et Biophysica Acta|June 12, 2016

Metabolic signatures of Huntington's disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brainStewart F Graham, Praveen K Kumar, Trent Bjorndahl, et al.

Cancer|February 15, 2013

A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancerMatthew G Fury, Eric Sherman, Alan L Ho, et al.

British Journal of Cancer|October 26, 2019

Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapyThomas H Beckham, Jonathan E Leeman, Peng Xie, et al.

Clinical Lung Cancer|December 10, 2003

Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patientsChristian S Adonizio, James S Babb, Christine Maiale, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002

Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intentIman Osman, Eric Sherman, Bhuvanesh Singh, et al.

The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|February 12, 2020

Metabolomic identification of placental alterations in fetal growth restrictionRay O Bahado-Singh, Onur Turkoglu, Ali Yilmaz, et al.

Future Oncology (London, England)|August 15, 2022

LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve <i>RET</i>-mutant medullary thyroid cancerLori J Wirth, Marcia S Brose, Rossella Elisei, et al.

International Journal of Particle Therapy|September 5, 2022

Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation TherapyIrini Youssef, Jennifer Yoon, Nader Mohamed, et al.

Cancer|March 15, 2012

A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancerMatthew G Fury, Nancy Y Lee, Eric Sherman, et al.

Pageof 10

Search research articles

Showing results (41-50 of 92) with videos related to